The first demonstration of an indirect effect has been highlighted by Brouty-Boye and colleagues who showed that the administration of IFNs increased the survival of mice affected by lymphocytic leukemia, regardless of the intrinsic sensibility of tumor cells to IFN preparations (28). Here, IFNA1 is linked to neoplasm.